Trials / Unknown
UnknownNCT03108456
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,005 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial will evaluate Orbital Atherectomy compared to conventional balloon angioplasty technique for the treatment of severely calcified lesions prior to implantation of drug-eluting stents (DES).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Orbital Atherectomy | Vessel preparation with Orbital Atherectomy followed by balloon pre-dilatation |
| DEVICE | Balloon | Vessel preparation with conventional and/or specialty balloons |
Timeline
- Start date
- 2017-03-27
- Primary completion
- 2024-06-12
- Completion
- 2025-06-12
- First posted
- 2017-04-11
- Last updated
- 2023-10-06
Locations
104 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03108456. Inclusion in this directory is not an endorsement.